Cooper Companies (COO) Research & Development (2009 - 2026)
Cooper Companies (COO) recorded quarterly Research & Development of $42.5 million in Q2 2026, down 4.06% quarter-over-quarter from $44.3 million in Q1 2026, and down 6.59% year-on-year from $45.5 million in Q2 2025.
Cooper Companies (COO) Research & Development (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Research & Development across 18 years of filings, most recently posting $42.5 million for Q2 2026.
- For the quarter ending Q2 2026, Research & Development fell 6.59% year-over-year to $42.5 million; the trailing twelve-month figure through Apr 2026 stood at $172.8 million (up 6.08% YoY), and the FY2025 full-year result was $172.2 million, up 11.03% from the prior year.
- Research & Development was $42.5 million for Q2 2026 at Cooper Companies, down from $44.3 million in the prior quarter.
- Over five years, Research & Development peaked at $45.5 million in Q2 2025 and troughed at $26.2 million in Q1 2022.
- The 5-year median for Research & Development is $38.3 million (2024), against an average of $36.8 million.
- The sharpest annual moves came in 2023 and 2026: Research & Development gained 27.18% in 2023, then declined 6.59% in 2026.
- Year by year, Research & Development stood at $29.1 million in 2022, then gained by 26.12% to $36.7 million in 2023, then advanced by 2.72% to $37.7 million in 2024, then gained by 9.81% to $41.4 million in 2025, then advanced by 2.66% to $42.5 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $42.5 million in Q2 2026, $44.3 million in Q1 2026, and $41.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 42.50 Mn |
| Jan 31, 2026 | 44.30 Mn |
| Oct 31, 2025 | 41.40 Mn |
| Jul 31, 2025 | 44.60 Mn |
| Apr 30, 2025 | 45.50 Mn |
| Jan 31, 2025 | 40.70 Mn |
| Oct 31, 2024 | 37.70 Mn |
| Jul 31, 2024 | 39.00 Mn |
| Apr 30, 2024 | 38.90 Mn |
| Jan 31, 2024 | 39.50 Mn |
| Oct 31, 2023 | 36.70 Mn |
| Jul 31, 2023 | 36.50 Mn |
| Apr 30, 2023 | 32.60 Mn |
| Jan 31, 2023 | 31.60 Mn |
| Oct 31, 2022 | 29.10 Mn |
| Jul 31, 2022 | 28.70 Mn |
| Apr 30, 2022 | 26.30 Mn |
| Jan 31, 2022 | 26.20 Mn |
| Oct 31, 2021 | 25.70 Mn |
| Jul 31, 2021 | 24.80 Mn |